PO23-777 EFFECT OF EZETIMIBE/SIMVASTATIN VERSUS ATORVASTATIN ON ATTAINING RECOMMENDED LEVELS OF LDL-C, APOLIOPROTEIN B, NON-HDL-C AND HS-CRP IN TYPE 2 DIABETES

✍ Scribed by Weinstock, R.S.; Goldberg, R.B.; Guyton, J.R.; Mazzone, T.; Polis, A.; Tomassini, J.E.; Desrosiers, E.; Tershakovec, A.M.

• Book ID: 118635617
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 72 KB
• Volume: 8
• Category: Article
• ISSN: 1567-5688
• DOI: 10.1016/s1567-5688(07)71787-7